A recent article published by M. Ruscica et al in European Journal of Internal Medicine titled “Statin therapy and related risk of new-onset type 2 diabetes mellitus.” provides unique insight into the connection between the use of statin drugs and new onset diabetes.  For clarity, statin drugs are a class of cholesterol-lowering medications including Lipitor, Crestor, Zocor, and others.

This research team states “Although statin therapy is rather well tolerated, recent data from prospective and retrospective clinical trials and related meta-analyses suggest an increased incidence of new-onset type 2 diabetes mellitus (T2DM) in association with such treatment. The incidence of this adverse effect is not negligible, especially for specific subsets of patients, such as women, elderly, presence of familial history of T2DM and Asian ethnicity.”

Some studies currently estimate that the increased risk for diabetes posed by statin use is between 10%-30%.  While statin drugs are currently very important in lowering the risk for cardiovascular disease, it is important that users be aware of all risks associated with medications used.

Unfortunately, the manufacturers of Lipitor and other statins have failed time and again to adequately inform users of this risk, and as a result, a number of Lipitor lawsuits have been filed.  If you or a loved one used Lipitor and received a diabetes diagnosis, you may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Lipitor lawyers at the information provided below.  We have the compassion, resources, and experience required to win the justice you deserve.

Call today and see how we can help.

(855) 452 – 5529


Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.